moclobemide has been researched along with Headache in 7 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An international, multicentre, double blind parallel group study compared the tolerability and efficacy of moclobemide with the selective serotonin reuptake inhibitor (SSRI) fluoxetine for panic disorder." | 9.09 | Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group. ( Behnke, K; Bouwer, C; Tiller, JW, 1999) |
| "While on this therapy, 35 of the 42 migraine patients and 16 of the 17 patients with tension-type headache experienced good or very good improvement in their symptoms." | 5.30 | [Preventive treatment of migraine and chronic tension headache with moclobemide]. ( Amsler, F; Meienberg, O, 1997) |
| "An international, multicentre, double blind parallel group study compared the tolerability and efficacy of moclobemide with the selective serotonin reuptake inhibitor (SSRI) fluoxetine for panic disorder." | 5.09 | Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group. ( Behnke, K; Bouwer, C; Tiller, JW, 1999) |
| " There were 188 adverse events: insomnia, dizziness, headache, nausea, dry mouth and myoclonic jerks were the most common." | 2.68 | Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients. ( Hawley, CJ; McPhee, S; Pattinson, HA; Quick, SJ; Ratnam, S, 1996) |
| "Moclobemide treatment, however, increased the incidence of adverse events elicited by ephedrine, particularly palpitations and headache." | 2.68 | Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A-inhibitor moclobemide. ( Dingemanse, J; Gieschke, R; Guentert, T; Stabl, M, 1996) |
| " A metaregression did not reveal a statistically significant relation between the mean moclobemide dosage for each study and the risk ratio for response rates." | 2.43 | A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. ( Fava, M; Papakostas, GI, 2006) |
| "While on this therapy, 35 of the 42 migraine patients and 16 of the 17 patients with tension-type headache experienced good or very good improvement in their symptoms." | 1.30 | [Preventive treatment of migraine and chronic tension headache with moclobemide]. ( Amsler, F; Meienberg, O, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papakostas, GI | 1 |
| Fava, M | 1 |
| Hawley, CJ | 1 |
| Quick, SJ | 1 |
| Ratnam, S | 1 |
| Pattinson, HA | 1 |
| McPhee, S | 1 |
| Versiani, M | 1 |
| Nardi, AE | 1 |
| Mundim, FD | 1 |
| Pinto, S | 1 |
| Saboya, E | 1 |
| Kovacs, R | 1 |
| Dingemanse, J | 1 |
| Guentert, T | 1 |
| Gieschke, R | 1 |
| Stabl, M | 1 |
| Meienberg, O | 1 |
| Amsler, F | 1 |
| Juruena, MF | 1 |
| Pires, ML | 1 |
| Calil, HM | 1 |
| Tiller, JW | 1 |
| Bouwer, C | 1 |
| Behnke, K | 1 |
1 review available for moclobemide and Headache
| Article | Year |
|---|---|
A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Topics: Depressive Disorder, Major; Disorders of Excessive Somnolence; Fatigue; Headache; Humans; Imipramine | 2006 |
5 trials available for moclobemide and Headache
| Article | Year |
|---|---|
Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients.
Topics: Adult; Benzamides; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Headache; Hum | 1996 |
The long-term treatment of social phobia with moclobemide.
Topics: Adolescent; Adult; Benzamides; Female; Headache; Humans; Male; Middle Aged; Moclobemide; Monoamine O | 1996 |
Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A-inhibitor moclobemide.
Topics: Adrenergic Agents; Adult; Benzamides; Blood Pressure; Double-Blind Method; Drug Synergism; Ephedrine | 1996 |
Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
Topics: Adult; Antidepressive Agents; Benzamides; Euphoria; Headache; Humans; Male; Moclobemide; Monoamine O | 1997 |
Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
Topics: Adult; Benzamides; Double-Blind Method; Female; Fluoxetine; Headache; Humans; Male; Moclobemide; Mon | 1999 |
1 other study available for moclobemide and Headache
| Article | Year |
|---|---|
[Preventive treatment of migraine and chronic tension headache with moclobemide].
Topics: Adult; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Headache; | 1997 |